How A Drugmaker Gamed The System to Keep Generic Competition Away
Celgene Corp. has thwarted rival drugmakers eager to make cheaper versions of medicines for a form of blood cancer. Now administration officials are criticizing practices they say hold generics back.
Read more on NPR
May 17, 2018 at 04:00PM
Health Care
Thứ Năm, 17 tháng 5, 2018
Đăng ký:
Đăng Nhận xét (Atom)
0 nhận xét:
Đăng nhận xét